PPA
AMRX icon

Parametric Portfolio Associates’s Amneal Pharmaceuticals AMRX Stock Holding History

Parametric Portfolio Associates’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$932K Buy
223,514
+13,230
+6% +$58.6K ﹤0.01% 2813
2021
Q4 		$1.01M Sell
210,284
-32,763
-13% -$163K ﹤0.01% 2782
2021
Q3 		$1.3M Buy
243,047
+43,808
+22% +$221K ﹤0.01% 2680
2021
Q2 		$1.02M Sell
199,239
-134,259
-40% -$763K ﹤0.01% 2764
2021
Q1 		$2.24M Buy
333,498
+194,851
+141% +$1.08M ﹤0.01% 2707
2020
Q4 		$634K Sell
138,647
-51,937
-27% -$230K ﹤0.01% 3265
2020
Q3 		$739K Sell
190,584
-33,456
-15% -$143K ﹤0.01% 3083
2020
Q2 		$1.07M Sell
224,040
-12,720
-5% -$52.4K ﹤0.01% 2894
2020
Q1 		$824K Buy
236,760
+34,611
+17% +$147K ﹤0.01% 2904
2019
Q4 		$974K Buy
202,149
+91,199
+82% +$317K ﹤0.01% 3072
2019
Q3 		$322K Buy
110,950
+81,430
+276% +$284K ﹤0.01% 3502
2019
Q2 		$212K Sell
29,520
-54,139
-65% -$554K ﹤0.01% 3723
2019
Q1 		$1.19M Sell
83,659
-63,964
-43% -$845K ﹤0.01% 2946
2018
Q4 		$2M Sell
147,623
-42,026
-22% -$757K ﹤0.01% 2590
2018
Q3 		$4.21M Sell
189,649
-45,359
-19% -$955K ﹤0.01% 2161
2018
Q2 		$3.86M Buy
+235,008
New +$4.12M ﹤0.01% 2175

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parametric Portfolio Associates's AMRX Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Amneal Pharmaceuticals (AMRX) stake by 6.3% in Q1 2022, buying an estimated $58.6K and bringing the position to 223,514 shares worth $932K. The position accounts for ﹤0.01% of the portfolio, ranked #2813.

Parametric Portfolio Associates first reported a position in AMRX in Q2 2018 and has held it in 16 quarters since. The position peaked at $4.21M in Q3 2018. 168 funds tracked by Wall St. Rank hold AMRX as of Q1 2022.

  • Parametric Portfolio Associates held 223,514 shares of Amneal Pharmaceuticals worth $932K as of Q1 2022.
  • Parametric Portfolio Associates bought 13,230 Amneal Pharmaceuticals shares in Q1 2022, an estimated $58.6K.
  • Amneal Pharmaceuticals made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2813 holding.
  • Parametric Portfolio Associates first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 16 quarters since.
  • Parametric Portfolio Associates's Amneal Pharmaceuticals position peaked at $4.21M in Q3 2018.
  • 168 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.